Somnomed (ASX:SOM)
ASX announcement history & article coverage
Transparent by design.
Announcments by Somnomed (ASX:SOM) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change in substantial holding
Notification of cessation of securities - SOM
Change of Director's Interest Notice
Change of Director's Interest Notice
Change of Director's Interest Notice
Change of Director's Interest Notice
Securities Trading Policy
Corporate Governance Statement
Appendix 4G
Investor presentation
SomnoMed FY26 revenue up 3%, EBITDA up 19%, targets high single digit growth in FY27
Full year results announcement FY26
SomnoMed FY26 revenue up 3%, EBITDA up 19%, new CEO appointed, Virtus product launched
Full Year Statutory Accounts
SomnoMed FY26 revenue up 3%, EBITDA up 19%, CEO transition, launches new device, targets growth in FY27
Notification of cessation of securities - SOM
FY26 Results announcement date and Webinar Invitation
Securities Trading Policy
Final Director's Interest Notice
Executive management update & unaudited FY26 results
SomnoMed announces CEO change, reports preliminary FY26 results below guidance, launches new product Virtus™
Change of Director's Interest Notice
Application for quotation of securities - SOM
Application for quotation of securities - SOM